In this issue:2025 POSTER ABSTRACTS SUPPLEMENTIt is my distinct honor to introduce this special supplement to the Journal of Drugs in Dermatology (JDD) featuring abstracts presented at the 2025 Annual…
Read More
INTRODUCTIONHyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, solar lentigines, and drug-induced pigmentation are common dermatologic complaints, particularly in patients with skin of color. These conditions can have significant psychosocial impacts,…
Read More
INTRODUCTIONPost-inflammatory hyperpigmentation (PIH) is a common acquired condition resulting from an overproduction of melanin or abnormal deposition of melanin in the epidermis or dermis following inflammation.1 PIH can appear following…
Read More
INTRODUCTIONExosomes are extracellular vesicles released by cells that transfer proteins, lipids, mRNAs, and microRNAs to recipient cells playing a role in intercellular communication.1 Recent studies have highlighted exosomes' role in…
Read More
INTRODUCTIONIncreasingly, therapeutic advancements in dermatology favor targeted modalities, such as monoclonal antibodies and biologic therapies, which specifically address inflammatory cytokines, offering alternatives to broader immunosuppressive treatments.1,2 Janus kinase (JAK) inhibitors…
Read More
INTRODUCTIONHyperpigmentation and dyschromia are amongst the most common dermatologic concerns for patients seeking care.1 They can affect patients of all skin types and ages, and most commonly occurs after inflammation…
Read More
In this issue:INDIVIDUAL ARTICLE: Real World Use of Topical Tranexamic Acid Serum in Patients With HyperpigmentationHyperpigmentation and dyschromia are amongst the most common dermatologic concerns for patients seeking care.1 They…
Read More
INTRODUCTIONDystrophic epidermolysis bullosa (DEB), caused by mutations in COL7A1 is characterized by the development of blisters, bullae, and erosions following minor trauma to the skin and mucous membranes, with healing…
Read More
INTRODUCTIONThe United States Medical Licensing Examination (USMLE) will stop reporting a 3-digit numerical score and begin reporting a pass/fail outcome at the end of January 2022.1,2 The proposal for this…
Read More
INTRODUCTIONDermatoporosis is a term first coined by Kaya and Saurat in 2007, describing progressive skin thinning, extracellular matrix (ECM) degradation, vascular fragility with resultant purpura, and general vulnerability of the…
Read More
INTRODUCTIONHyperhidrosis (HH) is defined as excessive sweating beyond the physiologic requirements of thermoregulation.1 HH is classified as either primary (idiopathic) or secondary to an underlying medical condition or medication.1 Primary…
Read More
INTRODUCTIONNail disorders encompass a broad spectrum of infectious, inflammatory, neoplastic, and traumatic conditions that may present with overlapping clinical features. They represent approximately 10% of all dermatologic conditions, accounting for…
Read More
